Find clinical trials for Eczema in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Eczema trials near New Haven, CT, USA:
The purpose of this study is to test if treatment with tralokinumab is safe and effectful to treat moderate-to-severe atopic hand eczema. Th...
Phase 3
Farmington, Connecticut, United States and 75 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Shelton, Connecticut, United States and 179 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
Farmington, Connecticut, United States and 86 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Farmington, Connecticut, United States and 95 other locations
amount of study medicine in the blood.The study medicine is developed for the treatment of moderate to severe atopic dermatitis, also known as eczema...
Phase 1
New Haven, Connecticut, United States
assigned dose or be reassigned to a different dose based on their Eczema Area and Severity Index (EASI) response. Approximately 300 adult pa...
Phase 3
New Haven, Connecticut, United States and 93 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Bridgeport, Connecticut, United States of America and 194 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Shelton, Connecticut, United States and 192 other locations
This is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A...
Phase 2
New Haven, Connecticut, United States and 79 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Farmington, Connecticut, United States and 342 other locations
Clinical trials
Research sites
Resources
Legal